Platelet aggregation-IN-2
Platelet aggregation-IN-2 is an anti-platelet aggregation agent with significant anticoagulant activity. Platelet aggregation-IN-2 can inhibit platelet aggregation reaction and reduce the risk of thrombosis. The application of Platelet aggregation-IN-2 can potentially be used for the prevention and suppression of cardiovascular diseases[1].
Product Specifications
CAS Number
[41552-94-7]
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/platelet-aggregation-in-2.html
Smiles
O[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(NCCC4=CC=C(C=C4)O)=C3N=C2)O[C@@H]1CO
Molecular Formula
C18H21N5O5
Molecular Weight
387.39
References & Citations
[1]Platelet aggregation inhibitors. 4. N 6 -substituted adenosines
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rat Monoclonal Integrin alpha 2b/CD41 Antibody (MWReg30) [Allophycocyanin/Cy7]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
Rat Monoclonal Integrin alpha 2b/CD41 Antibody (MWReg30) [Allophycocyanin/Cy7]
Mouse Monoclonal CYRPTIC/CFC1 Antibody (MM0205-8D12) [Alexa Fluor 647]
